19 results
·
14ms
·
Sources: EU EUDAMED, US FDA
Diathermy, Shortwave, For Use Other Than Applying Therapeutic Deep Heat
FDA classification
FDA Class 2
·Diathermy, Shortwave, For Use Other Than Applying Therapeutic Deep Heat
Erchonia CLX (Model # CFL)
FDA 510(k)
FDA Class 2
·General, Plastic Surgery
Straumann BLX Implant System
FDA 510(k)
FDA Class 2
·Dental
Straumann BLX Variobase Abutment
FDA 510(k)
FDA Class 2
·Dental
Straumann BLX Surgical Cassette
FDA 510(k)
FDA Class 2
·General Hospital
Straumann BLX Implant System
FDA 510(k)
FDA Class 2
·Dental
Straumann BLX Gold Abutments
FDA 510(k)
FDA Class 2
·Dental
Straumann BLX Ø3.5 mm Implants
FDA 510(k)
FDA Class 2
·Dental
Straumann BLX Line Extension - New Abutments
FDA 510(k)
FDA Class 2
·Dental
Straumann BLX Temporary Abutment, VITA CAD-Temp, PMMA
FDA 510(k)
FDA Class 2
·Dental
INVACARE PLATINUM, MODELS IRC 5LX AND IRC 5LX02
FDA 510(k)
FDA Class 2
·Anesthesiology
Straumann BLX Line Extension - Implants, SRAs and Anatomic Abutments
FDA 510(k)
FDA Class 2
·Dental
Atlantis® Abutments in Titanium for Straumann BLX and Neodent GM Implants
FDA 510(k)
FDA Class 2
·Dental
BLX WB Ø5.0 (L18), Ø5.5 and Ø6.5 mm (L14 and L16) Implants
FDA 510(k)
FDA Class 2
·Dental
Inclusive® Titanium Abutments compatible with: Keystone® Dental PrimaConnex®, Neodent® GM, Straumann® BLX, Implant Direct® Legacy®, Implant Direct® InterActive®, Implant Direct® RePlant® Implant Systems
FDA 510(k)
FDA Class 2
·Dental
Hemagglutination Inhibition, Barbiturate
FDA classification
FDA Class 2
·Hemagglutination Inhibition, Barbiturate
Photostimulator, Ac-Powered
FDA classification
FDA Class 2
·Photostimulator, Ac-Powered
Device To Detect And Identify Selected Microbial Agents That Cause Acute Febrile Illness
FDA classification
FDA Class 2
·Device To Detect And Identify Selected Microbial Agents That Cause Acute Febrile Illness
Assay To Measure Pct To Aid In The Risk Assessment Of Critically Ill Patients On Their First Day Of Icu Admission
FDA classification
FDA Class 2
·Assay To Measure Pct To Aid In The Risk Assessment Of Critically Ill Patients On Their First Day Of Icu Admission